P.463 Evaluation of three-monthly palmitate paliperidone long-acting formulation use in clinical practice based on the French healthcare claim database

Autor:	J. Boursicot-Beuzelin, Charlotte Gary, S. Bouju, Bruno Falissard, J.Y. Giordana, P. Guillon, C. Déal, E. Fakra, C. Tessier, S. Bouée, Ludovic Samalin
Rok vydání:	2020
Předmět:	Pharmacology medicine.medical_specialty business.industry Clinical Practice Psychiatry and Mental health Long acting Neurology Family medicine Health care medicine Pharmacology (medical) Paliperidone Neurology (clinical) business Biological Psychiatry medicine.drug
Zdroj:	European Neuropsychopharmacology. 40:S261-S262
ISSN:	0924-977X
DOI:	10.1016/j.euroneuro.2020.09.340
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::781cfdc01ed3b02642edfd65182e7fd6 https://doi.org/10.1016/j.euroneuro.2020.09.340 Zobrazit plný text záznamu Full Text from ScienceDirect